Entities / Company
Esperion Therapeutics.
American pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 34
What's happening
Gone quiet
No new reports in 90+ days-
Cantor Fitzgerald provided analyst coverage and targets for Esperion Therapeutics.Some support1 report
-
Esperion Therapeutics stock is trading on the Nasdaq exchange.Some support1 report
-
FDA approved oral, once-daily, non-statin medicines on August 26, 2025.Some support3 reports1 development inside
-
Settlement agreement restricts generic market due to FDA approval of oral non-statin medicines, leading to ongoing patent litigation against Renata Limited.Speculative1 report
-
Accord Healthcare and Esperion Therapeutics reached a settlement agreement that delays the generic version release.Speculative1 report
-
Esperion Therapeutics operates within the biopharmaceutical sector and its stock underperformed the broader market index on August 5, 2025.Some support1 report
-
The FDA approved two drugs in Esperion's portfolio, and Daiichi Sankyo Europe received a milestone from Esperion, which has a collaboration with Otsuka in Japan.Some support1 report
-
Esperion Therapeutics licensed products to HLS Therapeutics Inc. for commercialization in the Canadian market.Some support1 report
-
On August 23, 2025, Kevin Matras used a high-powered approach to close winners for Esperion Therapeutics.Some support1 report
-
Esperion Therapeutics, based in the state of Michigan, has been manufacturing ingredients at its campus in Petersburg since May 26, 2026.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Esperion Therapeutics this week
News at the entities that move Esperion Therapeutics most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Esperion Therapeutics
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Esperion Therapeutics
-
Cantor Fitzgerald Mentioned togetherAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves Esperion Therapeutics
-
Michigan Shared contextGeotab is expanding its operations in Michigan, supported by state grants and programs.Moves Esperion Therapeutics
-
Needham Mentioned togetherA data center project involving DeepGreen Cook Inlet is seeking preliminary permits from the FERC while facing opposition from the Kenai Peninsula Borough.Moves Esperion Therapeutics
Connections
The 5 strongest of 34, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Esperion Therapeutics by approving drugs within its portfolio.
-
Nasdaq Structural
Esperion Therapeutics is a publicly traded company listed on the Nasdaq exchange.
-
Michigan Shared context
The company was based in the state of Michigan.
-
Needham Mentioned together
The relationship is based on shared analyst coverage and market targets discussed in financial reports.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provides analyst coverage and targets for Esperion Therapeutics.
History
Events by the month they beganJune 2026
10 events- Cantor Fitzgerald provided analyst coverage and targets for Esperion Therapeutics.
- Esperion Therapeutics stock is trading on the Nasdaq exchange.
- FDA approved oral, once-daily, non-statin medicines on August 26, 2025.
- Settlement agreement restricts generic market due to FDA approval of oral non-statin medicines, leading to ongoing patent litigation against Renata Limited.
- Accord Healthcare and Esperion Therapeutics reached a settlement agreement that delays the generic version release.
- Esperion Therapeutics operates within the biopharmaceutical sector and its stock underperformed the broader market index on August 5, 2025.
- The FDA approved two drugs in Esperion's portfolio, and Daiichi Sankyo Europe received a milestone from Esperion, which has a collaboration with Otsuka in Japan.
- Esperion Therapeutics licensed products to HLS Therapeutics Inc. for commercialization in the Canadian market.
- On August 23, 2025, Kevin Matras used a high-powered approach to close winners for Esperion Therapeutics.
- Esperion Therapeutics, based in the state of Michigan, has been manufacturing ingredients at its campus in Petersburg since May 26, 2026.